UNITED
STATES
|
SECURITIES
AND EXCHANGE COMMISSION
|
WASHINGTON,
DC 20549
|
FORM
8-K
|
CURRENT
REPORT PURSUANT
|
TO
SECTION 13 OR 15(D) OF THE
|
SECURITIES
EXCHANGE ACT OF 1934
|
Date
of report (Date of earliest event reported):
|
April
18, 2010
|
BOVIE
MEDICAL CORPORATION
|
(Exact
Name of Registrant as Specified in Its Charter)
|
Delaware
|
(State
or Other Jurisdiction of Incorporation or
Organization)
|
012183
|
11-2644611
|
|||
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
734 Walt Whitman Road, Melville, New York
11747
|
(Address
of Principal Executive Offices, Including Zip
Code)
|
(631)
421-5452
|
(Registrant’s
Telephone Number, Including Area Code)
|
(Former
Name or Former Address, if Changed Since Last
Report)
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
10.1
|
Securities
Purchase Agreement, dated April 18, 2010, by and among Bovie Medical
Corporation and the investors listed on the Schedule of Buyers attached
thereto.
|
10.2
|
Form
of Registration Rights Agreement by and among Bovie Medical Corporation
and the investors listed on the signature pages
thereto.
|
10.3
|
Form
of Warrant to be issued to the Buyers under the Securities Purchase
Agreement.
|
10.4
|
Form
of Warrant to be issued to Rodman & Renshaw, LLC and Gilford
Securities Inc.
|
BOVIE
MEDICAL CORPORATION
|
||||||
Date:
April 19, 2010
|
/s/
Andrew Makrides
|
|||||
Name:
Andrew Makrides
|
||||||
Title: President
and
Chairman of the
Board
|
||||||